P&G Health fixes record date for dividend payment

0 min read     Updated on 26 May 2026, 07:46 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Procter & Gamble Health Limited announced August 21, 2026 as the record date for its 59th Annual General Meeting and dividend payment. The AGM is set for August 27, 2026. Dividend payout is subject to shareholder approval at the meeting.

powered bylight_fuzz_icon
41350590

*this image is generated using AI for illustrative purposes only.

Procter & Gamble Health Limited has fixed August 21, 2026 as the record date for its 59th Annual General Meeting and dividend payment. The company announced that the Annual General Meeting is scheduled to be held on August 27, 2026. Shareholders registered on the record date will be eligible to participate in the meeting and receive the dividend, subject to approval by the members at the ensuing Annual General Meeting.

The disclosure was submitted to the stock exchanges by Zeal Bhavin Rupani, Company Secretary of Procter & Gamble Health Limited. The notification was addressed to The BSE Limited and The National Stock Exchange of India Limited to ensure compliance with regulatory requirements.

Key Details

Event Date
Record Date August 21, 2026
59th Annual General Meeting August 27, 2026

The dividend payment is contingent upon approval by the shareholders during the Annual General Meeting. Procter & Gamble Health Limited has its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri-E, Mumbai.

Historical Stock Returns for Procter & Gamble Health

1 Day5 Days1 Month6 Months1 Year5 Years
+10.53%+16.98%+21.58%+7.43%+15.72%+4.42%

What dividend payout ratio is the company targeting for the upcoming fiscal year?

How might the dividend announcement impact investor sentiment and stock liquidity ahead of the record date?

What strategic initiatives or growth areas will be highlighted during the 59th Annual General Meeting?

Procter & Gamble Health
View Company Insights
View All News
like18
dislike

Procter & Gamble Health re-appoints S. Madhavan as Independent Director for five years

1 min read     Updated on 26 May 2026, 07:09 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Procter & Gamble Health Limited's Board has approved the re-appointment of Mr. S. Madhavan as Independent Director for a term of five years effective November 15, 2026, subject to shareholder approval. Mr. Madhavan meets the independence criteria under Section 149 of the Companies Act, 2013 and SEBI regulations.

powered bylight_fuzz_icon
41348357

*this image is generated using AI for illustrative purposes only.

Procter & Gamble Health Limited's Board has approved the re-appointment of Mr. S. Madhavan as Independent Director for a term of five years effective November 15, 2026. The decision, taken at a Board meeting held on May 26, 2026, follows the recommendation of the company's Nomination & Remuneration Committee. The re-appointment is subject to the approval of the shareholders.

The company confirmed that Mr. Madhavan meets the criteria of independence laid down in Section 149 of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It was further affirmed that he is not debarred or disqualified from holding the office of a Director by any order from SEBI, the Ministry of Corporate Affairs, or any other statutory authority. Additionally, Mr. Madhavan does not hold any shares in the company.

The re-appointment is pursuant to the completion of Mr. Madhavan's first tenure. The company provided the requisite details in compliance with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Re-appointment Details

Detail Information
Reason of Change Re-appointment of Mr. S. Madhavan as Independent Director for a period of five years pursuant to completion of first tenure.
Date of Re-appointment November 15, 2026
Term of Re-appointment Five (5) years, i.e., from November 15, 2026 to November 14, 2031. Subject to approval of shareholders.
Relationship with Directors None of the Directors of the Company are related to Mr. S. Madhavan.

Historical Stock Returns for Procter & Gamble Health

1 Day5 Days1 Month6 Months1 Year5 Years
+10.53%+16.98%+21.58%+7.43%+15.72%+4.42%

How will shareholders vote on Mr. Madhavan's re-appointment given his lack of equity stake in the company?

What strategic contributions did Mr. Madhavan make during his first tenure that justify his re-appointment?

Will Mr. Madhavan's re-appointment influence any upcoming changes in P&G Health's corporate governance policies?

Procter & Gamble Health
View Company Insights
View All News
like16
dislike

More News on Procter & Gamble Health

1 Year Returns:+15.72%